This new fundraising event for the Wright Memorial Hospital Foundation will be held on Saturday, October 7, at Crowder State Park, just outside the city limits of Trenton.
Saint Luke’s Health System has expanded its Hospital In Your Home program, now available to patients of Saint Luke’s South Hospital and residents of Kansas.
In the STEP-HFpEF trial, semaglutide improved symptoms, physical limitations and exercise function and reduced body weight in patients with obesity phenotype of heart failure and preserved ejection fraction (HFpEF).
The study shows that the diabetes and weight loss drug semaglutide significantly reduced symptoms and improved quality of life in people with obesity and the most common form of heart failure in a clinical trial.
Semaglutide, the active ingredient on weight loss drugs Wegovy and Ozempic, shows evidence that the drug may also help reduce the risks of heart disease.